Frequent UTIs shouldn’t be taken lightly. They may indicate a bigger problem. A top doctor explained their symptoms, causes, ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today ...
The surge in oil prices presents a challenge for South Africa, which relies heavily on energy imports. Oil prices have exceeded $100 a barrel, even as the US attempts to alleviate supply concerns by ...
This winter, avian influenza viruses have continued to circulate in wild birds across Pennsylvania, and more birds will be migrating to and through the state in the coming weeks. Strains of highly ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced new open-label extension study data for repinatrabit (JNT-517), demonstrating ...
A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...
News-Medical.Net on MSN
New review reveals complex polygenic architecture underlying common epilepsies
An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...
Mama Loves to Eat on MSN
The 2026 worst foods list: 4 popular grocery items already raising health concerns
You've probably walked through a grocery store a hundred times thinking you had a pretty good handle on what's healthy and what's not. The obvious offenders, the chips, the candy bars, seem easy ...
Fourth quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $57.3 million ---- March 20, 2026 PDUFA goal date ...
ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease ...
Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results